
Pharmacists can use medication therapy management to screen for diabetes, educate patients about medication adherence and lifestyle modifications, and support early action.
Below a certain GFR, clinically significant reductions in plasma glucose cannot be achieved with sodium-glucose transport protein 2 inhibitors.
Sodium-glucose transport protein 2 (SGLT2) inhibitors and glomerular filtration rate cutoffs:
Explanation:
Given their mode of action, which is heavily dependent on the glucose filtered load and therefore on GFR, the efficacy of SGLT2 inhibitors in reducing plasma glucose is expected to be decreased with decreasing renal function.
Below a certain GFR, clinically significant reductions in plasma glucose cannot be achieved with SGLT2s.
References





